Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandre V Ivachtchenko

Showing results (51-60 of 68) with videos related to

Pageof 7
Sort By:
Bioorganic & Medicinal Chemistry|June 15, 2010
Synthesis and biological study of 3-(phenylsulfonyl)thieno[2,3-e][1,2,3]triazolo[1,5-a]pyrimidines as potent and selective serotonin 5-HT6 receptor antagonistsAlexandre V Ivachtchenko, Elena S Golovina, Madina G Kadieva, et al.
Journal of Cancer|February 5, 2014
Preclinical Development of ONC1-13B, Novel Antiandrogen for Prostate Cancer TreatmentAlexandre V Ivachtchenko, Oleg D Mitkin, Elizaveta V Kudan, et al.
Journal of Medicinal Chemistry|June 22, 2010
(3-Phenylsulfonylcycloalkano[e and d]pyrazolo[1,5-a]pyrimidin-2-yl)amines: potent and selective antagonists of the serotonin 5-HT6 receptorAlexandre V Ivachtchenko, Dmitri E Dmitriev, Elena S Golovina, et al.
The Journal of Antimicrobial Chemotherapy|April 15, 2014
Novel oral anti-influenza drug candidate AV5080Alexandre V Ivachtchenko, Yan A Ivanenkov, Oleg D Mitkin, et al.
Current Topics in Medicinal Chemistry|November 21, 2015
In Silico Approaches to the Design of NS5A InhibitorsYan A Ivanenkov, Mark S Veselov, Vladimir A Aladinskiy, et al.
Bioorganic & Medicinal Chemistry Letters|March 9, 2010
Synthesis of cycloalkane-annelated 3-phenylsulfonyl-pyrazolo[1,5-a]pyrimidines and their evaluation as 5-HT6 receptor antagonistsAlexandre V Ivachtchenko, Dmitri E Dmitriev, Elena S Golovina, et al.
Current Topics in Medicinal Chemistry|November 21, 2015
A Comprehensive Insight into the Chemical Space and ADME Features of Small Molecule NS5A InhibitorsYan A Ivanenkov, Mark S Veselov, Artem G Shakhbazyan, et al.
European Journal of Medicinal Chemistry|June 6, 2015
Design, synthesis and biological evaluation of novel 5-oxo-2-thioxoimidazolidine derivatives as potent androgen receptor antagonistsAlexandre V Ivachtchenko, Yan A Ivanenkov, Oleg D Mitkin, et al.
The Journal of Antimicrobial Chemotherapy|January 17, 2014
Novel oral anti-influenza prodrug candidate AV5075SAlexandre V Ivachtchenko, Yan A Ivanenkov, Oleg D Mitkin, et al.
Bioorganic & Medicinal Chemistry Letters|May 27, 2008
Novel aryl and heteroaryl substituted N-[3-(4-phenylpiperazin-1-yl)propyl]-1,2,4-oxadiazole-5-carboxamides as selective GSK-3 inhibitorsAngela G Koryakova, Yan A Ivanenkov, Elena A Ryzhova, et al.
Pageof 7

Showing results (51-60 of 68) with videos related to

Sort By:
Pageof 7
Bioorganic & Medicinal Chemistry|June 15, 2010
Synthesis and biological study of 3-(phenylsulfonyl)thieno[2,3-e][1,2,3]triazolo[1,5-a]pyrimidines as potent and selective serotonin 5-HT6 receptor antagonistsAlexandre V Ivachtchenko, Elena S Golovina, Madina G Kadieva, et al.
Journal of Cancer|February 5, 2014
Preclinical Development of ONC1-13B, Novel Antiandrogen for Prostate Cancer TreatmentAlexandre V Ivachtchenko, Oleg D Mitkin, Elizaveta V Kudan, et al.
Journal of Medicinal Chemistry|June 22, 2010
(3-Phenylsulfonylcycloalkano[e and d]pyrazolo[1,5-a]pyrimidin-2-yl)amines: potent and selective antagonists of the serotonin 5-HT6 receptorAlexandre V Ivachtchenko, Dmitri E Dmitriev, Elena S Golovina, et al.
The Journal of Antimicrobial Chemotherapy|April 15, 2014
Novel oral anti-influenza drug candidate AV5080Alexandre V Ivachtchenko, Yan A Ivanenkov, Oleg D Mitkin, et al.
Current Topics in Medicinal Chemistry|November 21, 2015
In Silico Approaches to the Design of NS5A InhibitorsYan A Ivanenkov, Mark S Veselov, Vladimir A Aladinskiy, et al.
Bioorganic & Medicinal Chemistry Letters|March 9, 2010
Synthesis of cycloalkane-annelated 3-phenylsulfonyl-pyrazolo[1,5-a]pyrimidines and their evaluation as 5-HT6 receptor antagonistsAlexandre V Ivachtchenko, Dmitri E Dmitriev, Elena S Golovina, et al.
Current Topics in Medicinal Chemistry|November 21, 2015
A Comprehensive Insight into the Chemical Space and ADME Features of Small Molecule NS5A InhibitorsYan A Ivanenkov, Mark S Veselov, Artem G Shakhbazyan, et al.
European Journal of Medicinal Chemistry|June 6, 2015
Design, synthesis and biological evaluation of novel 5-oxo-2-thioxoimidazolidine derivatives as potent androgen receptor antagonistsAlexandre V Ivachtchenko, Yan A Ivanenkov, Oleg D Mitkin, et al.
The Journal of Antimicrobial Chemotherapy|January 17, 2014
Novel oral anti-influenza prodrug candidate AV5075SAlexandre V Ivachtchenko, Yan A Ivanenkov, Oleg D Mitkin, et al.
Bioorganic & Medicinal Chemistry Letters|May 27, 2008
Novel aryl and heteroaryl substituted N-[3-(4-phenylpiperazin-1-yl)propyl]-1,2,4-oxadiazole-5-carboxamides as selective GSK-3 inhibitorsAngela G Koryakova, Yan A Ivanenkov, Elena A Ryzhova, et al.
Pageof 7